The MHC class II-associated invariant chain: A molecule with multiple roles in MHC class II biosynthesis and antigen presentation to CD4+ T cells

Critical Reviews in Immunology

Volumn 16, Issue 4, 1996, Pages 359-379

  Bertolino, Patrick ^a   Rabourdin Combe, Chantal ^a  

^a Univ Claude Bernard   (France)

Author keywords

antigen presentation; CD4+ T cells; CLIP; Ii; isoforms

Indexed keywords

CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; ENDOPLASMIC RETICULUM; ENDOSOME; GENE EXPRESSION REGULATION; HUMAN; INTRACELLULAR TRANSPORT; LYMPHOCYTE DIFFERENTIATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN QUATERNARY STRUCTURE; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CD4-POSITIVE T-LYMPHOCYTES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MICE;

EID: 0029966857     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (189)

1. Jones, P., Murphy, D. B., Hewgill, D., and McDevitt, H. O., Detection of a common polypeptide chain in I-A and I-E subregions immunoprecipitates, Immunochemistry, 16, 51-60, 1978.
2. Charron D. J. and McDevitt, H. O., Analysis of HLA-D region associated molecules with monoclonal antibody, Proc Natl. Acad. Sci. U.S.A., 76, 6567-6571, 1979.
3. Stockinger, B., Pessara, U., Lin, R. H., Habicht, J., Grez, M., and Koch, N., A role of Ia-associated invariant chains in antigen processing and presentation, Cell, 56, 683-689, 1989.
4. Viville, S., Neefjes, J., Lotteau, V., Dierich, A., Le Meur, M., Ploegh, H., and Benoist, C. M. D., Mice lacking the MHC class II-associated invariant chain, Cell 72, 635-648, 1993.
5. + T cell selection in mice lacking invariant chain expression, J. Exp. Med., 177, 1699-1712, 1993.
6. Elliott, E. A., Drake, J. R., Amigorena, S., Elsemore, J., Webster, P., Mellman, I., and Flavell, R. A., The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules, J. Exp. Med., 179, 681-694, 1994.
7. Richards, J. E., Pravtcheva, D. D., Day, C., Ruddle, F. H., and Jones, P. P., Murine invariant chain gene: chromosomal assignment and segregation in recombinant inbred strains, Immunogenetics, 22, 193-199, 1985.
8. Yamamoto, K., Floyd-Smith, G., Francke, U., Koch, N., Lauer, W., Dobberstein, B., Schafer, R., and Hammerling, G. J., The gene encoding the Ia-associated invariant chain is located on chromosome 18 in the mouse, Immunogenetics, 21, 83-90, 1985.
9. Claesson, L., Larhammar, D., Rask, L., and Peterson, P. A., cDNA clone for the human invariant gamma chain of class II histocompatibility antigens and its implications for the protein structure, Proc. Natl. Acad. Sci. U.S.A., 80, 7395-7399, 1983.
10. Benoist, C. and Mathis, D., Regulation of major histocompatibiity complex class II genes: X, Y and other letters of the alphabet, Anna. Rev. Immunol., 8, 681-715, 1990.
11. Ting, J. P. Y. and Baldwin, A. S., Regulation of MHC gene expression, Curr. Opin. Immunol., 5, 8-16. 1993.
12. Polla, B. S., Poljack, A., Ohara, J., Paul, W. E., and Glimcher, L. H., Regulation of class II gene expression: analysis in B cell stimulatory factor I-inducible murine pre-B cell lines, J. Immunol., 136, 3332-3337, 1986.
13. Wong, G. H. W., Clarck-Lewis, L, McKimm-Breschkin, J. L., Harris, A. W., and Schrader, J. W., Interferon-γ induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage and myeloid cell lines, J. Immunol, 131, 788-796, 1983.
14. Wong, G. W. H., Clarck-Lewis, L, Harris, A. W., and Schrader, J. W., Effect of cloned interferon-γ on expression of H-2 and Ia antigens on cell lines of hemopoietic, lymphoid, epithelial, fibroblastic and neuronal origin, Eur. J. Immunol., 14, 52-60, 1984.
15. Steeg, P. S., Moore, R. N., Johnson, H. M., and Oppenheim, J. J., Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity, J.Exp.Med., 156, 1780-1792, 1982.
16. King, D. P. and Jones, P. P., Induction of Ia and H-2 antigens on a macrophage cell line by immune interferon, J. Immunol., 131, 315, 1983.
17. Chang, R. J. and Lee, S. H., Effects of interferon-γ and tumor necrosis factor-α on the expression of an MHC class II antigen on a murine macrophage cell line, J. Immunol., 135, 2853-2856, 1986.
18. Wong, G. H. W., Bartlett, P. F., Clarck-Lewis, I., Battye, F., and Shrader, J. W., Inducible expression of H-2 and Ia antigens on brain cells, Nature, 310, 688-691, 1984.
19. Momburg, F., Koch, N., Moller, P., Moldenhauer, G., Butcher, G. W., and Hämmerling, G. J., Differential expression of Ia and Ia-associated invariant chain in mouse tissues after in vivo treatment with IFN-gamma, J. Immunol., 136, 940-948, 1986.
20. Rahmsdorf, H. J., Harth, N., Eades, A. M., Litfin, M., Steinmetz, M., Forni, L., and Herrlich, P., Interferon-gamma, mitocycin C, and cycloheximide as regulatory agents of MHC class II-associated invariant chain expression, J. Immunol., 136, 2293-2299, 1986.
21. Pessara, U. and Koch, N., Tumor necrosis factor alpha regulates expression of the major histocompatibility complex class II-associated invariant chain by binding of an NF-kappa B-like factor to a promoter element, Mol. Cell. Biol., 10, 4146-4154, 1990.
22. Kolk, D. P. and Floyd-Smith, G., Induction of the murine class-II antigen associated invariant chain by TNF-a is controlled by an NF-kB-like element, Gene, 126, 179-185, 1993.
23. Zhu, L. and Jones, P. P., Transcriptional control of the invariant chain gene involves promoter and enhancer elements common to and distinct from major histocompatibility complex class II genes, Mol. Cell. Biol., 10, 3906-3916, 1990.
24. Ono, S. J., Liou, H. C., Davidson, R., and Strominger, J. L., Human X-box-binding protein 1 is required for the transcription of a subset of human class II major histocompatibility genes and form a heterodimer with c-fos, Proc. Natl. Acad. Sci. U.S.A., 88, 4309-4312, 1991.
25. Muegge, K. and Durum, S., From cell code to gene code: cytokines and transcription factors, New Biologist, 1, 239-246, 1989.
26. Long, E. O., Mach, B., and Accolla, R. S., Ia-negative B-cell variants revealed a coordinate regulation in the transcription of the HLA class II gene family, Immunogenetics, 19, 349-353, 1984.
27. Accolla, R. S., Carra, G., Buchegger, F., Carrel, S., and Mach, J. P., The human Ia-associated invariant chain is synthesized in Ia-negative B cell variants and is not expressed on the cell surface of both Ia-negative and Ia-positive parental cells, J. Immunol., 134. 3265-3271, 1985.
28. Lenardo, M. J. and Baltimore, D., NF-KB: a pleiotropic mediator of inducible and tissue-specific gene control, Cell, 58, 227-229, 1989.
29. Bertolino, P., Forquet, F., Pont, S., Koch, N., Gerlier, D., and Rabourdin-Combe, C., Correlation between invariant chain expression level and capability to present antigen to MHC class II-restricted T cells, Int. Immunol., 3, 435-443, 1991.
30. Yamamoto, K., Koch, N., Steinmetz, M., and Hämmerling, G. J., One gene encodes two distinct Ia-associated invariant chains, J. Immunol., 134, 3461-3466, 1985.
31. Strubin, M., Long, E. O., and Mach, B., Two forms of the Ia antigen-associated invariant chain result from alternative initiations at two in-phase AUGs, Cell, 47, 619-625, 1986.
32. O'Sullivan, D. M., Noonan, D., and Quarante, V., Four Ia invariant chain forms derive from a single gene by alternate splicing and alternate initiation of transcription/translation, J. Exp. Med., 166, 444-460, 1987.
33. Koch, N., Lauer, W., Habicht, J., and Dobberstein, B., Primary structure of the gene for the murine Ia antigen-associated invariant chains(Ii). An alternatively spliced exon encodes a cysteine-rich domain highly homologous to a repetitive sequence of thyroglobulin, EMBO J., 6, 1677-1683, 1987.
34. Sung, E. and Jones, P. P., The invariant chain of murine Ia antigens: its glycosylation, abundance and subcellular localization, Mol. ImmunoL, 18, 899-913, 1981.
35. Kvist, S., Wiman, K., Claesson, L., Peterson, A., and Dobberstein, B., Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens, Cell, 29, 61-69, 1982.
36. Machamer, C. E. and Cresswell, P., Biosynthesis and glycosylation of the invariant chain associated with HLA-DRantigens, J. Immunol., 129, 2564-2569, 1982.
37. Marks, M. S., Blum, J. S., and Cresswell, P., Invariant chain trimers are sequestered in the rough endoplasmic reticulum in the absence of association with HLA class II antigens, J. Cell Biol., 111, 839-855, 1990.
38. Bertolino, P., Staschewski, M., Trescol-Biemont, M. C., Freisewinkel, I. M., Schenck, K., Chretien, L, Forquet, F., Gerlier, D., Rabourdin-Combe, C., and Koch, N., Deletion of a C terminal sequence of the class II-associated invariant chain abrogates invariant chains oligomer formation and class II antigen presentation, J. Immunol., 154, 5620-5629, 1995.
39. Arneson, L. S. and Miller, J., Efficient endosomal localization of major histocompatibility complex class II-invariant chain complexes requires multimerization of the invariant chain targeting sequence, J. Cell Biol., 129, 1217-1228, 1995.
40. Lamb, C. A. and Cresswell, P., Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes, J. Immunol., 148, 3478-3482, 1992.
41. Bijlmakers, M. J., Benaroch, P., and Ploegh, H. L., Mapping functional regions in the lumenal domain of the class-II-associated invariant chain, J. Exp. Med., 180, 623-629, 1994.
42. Freisewinkel, I. M., Schanck, K., and Koch, N., The segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides, Proc. Natl. Acad. Sci. U.S.A., 90, 9703-9706, 1993.
43. Jasanoff, A., Park, S. J., and Wiley, D. C., Direct observation of disordered regions in the major histocompatibility complex class II-associated invariant chain, Proc. Natl. Acad. Sci. U.S.A., 92, 9900-9904, 1995.
44. Bangia, N. and Watts, T. H., Evidence for invariant chain 85-101 (CLIP) binding in the antigen binding site of MHC class II molecules, Int. Immunol., 7, 1585-1591, 1995.
45. Roche, P, A., Marks, M. S., and Cresswell, P., Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain, Nature, 354, 392-394, 1991.
46. Nijenhuis, M., Calafat, J., Kuijpers, K. C., Janssen, H., De Haas, M., Nordeng, T. W., Bakke, O., and Neefjes, J. J., Targeting major histocompatibility complex class II molecules to the cell surface by invariant chain allows antigen presentation upon recycling, EurJ. Immunol., 24, 873-883, 1994.
47. Bonnerot, C., Marks, M. S., Cosson, P., Robertson, E. J., Bikoff, E. K., Germain, R. N., and Bonifacino, J. S., Association with BiP and aggregation of class II MHC molecules synthesized in the absence of invariant chain, EMBO J., 13, 934-944, 1994.
48. Andersen, K. S. and Cresswell, P., A role for calnexin (IP90) in the assembly of class II MHC molecules, EMBO J., 13, 675-682, 1994.
49. Cowan, E. P., Cummings, R. D., Schwartz, B. D., and Cullen, S. E., Analysis of murine Ia antigen glycosylation by lectin affinity chromatography. I-Ak α chain subspecies and β are each glycosylated differently, J. Biol. Chem., 257, 11241-11248, 1982.
50. Sant, A., Zacheis, M., Rumbarger, T., Giacoletto, K. S., and Shwartz, B. D., Human Ia α and β chains are sulfated, J. Immunol., 140, 155-160, 1988.
51. Simonis, S. and Cullen, S., Fatty acylation of murine α, β and Ii chains, J. Immunol., 136, 2962-2967, 1986.
52. Koch, N. and Hämmerling, G. J., The HLA-D-associated invariant chain binds palmitic acid at the cysteine adjacent to the membrane segment, J. Biol. Chem., 261, 3434-3440, 1986.
53. Koch, N. and Hämmerling, G. J., Ia-associated invariant chain is fatty acylated before addition of sialic acid, Biochemistry, 24, 6185-6190, 1985.
54. Machamer, C. E. and Cresswell, P., Monensin prevents terminal glycosylation of the N- and O-linked oligosaccharides of the HLA-DR-associated invariant chain and inhibits its dissociation from the alpha-beta chain complex, Proc. Natl. Acad. Sci U.S.A., 81, 1287-1291, 1984.
55. k complex, J. Immunol., 135, 399-407, 1985.
56. Spiro, R. C. and Quaranta, V., The invariant chain is a phosphorylated subunit of class II molecules, J. Immunol., 143, 2589-2594, 1989.
57. Sant, A. J., Schwartz, B. D., and Cullen, S., Identification of a new component in the murine Ia molecular complex, J. Exp. Med., 158, 1979-1982, 1983.
58. Sant, A. J., Cullen, S. E., Giacoletto, K. S., and Schwartz, B. D., Invariant chain is the core protein of the Ia-associated chondroitin sulfate proteoglycan, J. Exp. Med., 162, 1916-1934, 1985.
59. Giacoletto, K. S., Sant, A. J., Bono, C., Gorka, J., O'Sullivan, D. M., Quaranta, V., and Schwartz, B. D., The human invariant chain is the core protein of the human class II-associated proteoglycan. J. Exp. Med., 164, 1422-1439, 1986.
60. Miller, J., Hatch, J. A., Simonis, S., and Cullen, S. E., Identification of the glycosaminoglycan-attachment site of mouse invariant-chain proteoglycan core protein by site-directed mutagenesis, Proc. Natl. Acad. Sci. U.S.A., 85, 1359-1363, 1988.
61. Teyton, L. and Peterson, P. A., Invariant chain: a regulator of antigen presentation, Trends In Cell Biol., 2, 52-56, 1992.
62. Koch, N., Posttranslational modifications of the Ia-associated invariant protein p41 after gene transfer, Biochem., 27, 4097-4102, 1988.
63. Romagnoli, P., Layet, C., Yewdell, J., Bakke, O., and Germain, R. N., Relationship between invariant chain expression and major histocompatibility complex class-II transport into early and late endocytic compartments, J. Exp. Med., 177, 583-596, 1993.
64. Arunachalam, B., Lamb, C. A., and Cresswell, P., Transport properties of free and MHC class II-associated oligomers containing different isoforms of human invariant chain, Int. Immunol., 6, 439-451, 1993.
65. Peterson, M. and Miller, J., Antigen presentation enhanced by the alternative spliced invariant chain product p41, Nature, 357, 596-598, 1992.
66. Lotteau, V., Teyton, L., Peleraux, A., Nilsson, T., Karlsson, L., Schmid, S. L., Quaranta, V., and Peterson, P. A., Intracellular transport of class II MHC molecules directed by invariant chain, Nature, 348, 600-605, 1990.
67. Dodi, A. I., Brett, S., Nordeng, T., Sidhu, S., Batchelor, R. J., Lombardi, G., Bakke, O., and Lechler, R. I., The invariant chain inhibits presentation of endogenous antigens by a human fibroblast cell line, Eur. J. Immunol., 24, 1632-1639, 1994.
68. Schultze, M. P., Peterson, P. A., and Jackson, M. R., An N-terminal double arginine motif maintains type II membrane proteins in the endoplasmic reticulum, EMBO J., 13, 1696-1705, 1994.
69. Nguyen, Q. V. and Humphreys, R. E., Time course of intracellular associations, processing and cleavages of Ii forms and class II major histocompatibility complex molecules, J. Biol. Chem., 264, 1631-1637, 1989.
70. Simonis, S., Miller, J., and Cullen, S. E., The role of the Ia-invariant chain complex in the post-translational processing and transport of Ia and invariant chain glycoproteins, J. Immunol., 143, 3619-3625, 1989.
71. Lamb, C. A., Yewdell, J. W., Bennink, J. R., and Cresswell, P., Invariant chain targets HLA class II molecules to acidic endosomes containing internalized influenza virus, Proc. Natl. Acad. Sci. U.S.A., 88, 5998-6002, 1991.
72. Chervonsky, A. and Sant, A. J., In the absence of major histocompatibility complex class II molecules, invariant chain is translocated to late endocytic compartments by autophagy, Eur. J. Immunol., 25, 911-918, 1995.
73. Bakke, O. and Dobberstein, B., MHC class II-associated invariant chain contains a sorting signal for endosomal compartments, Cell, 63, 707-716, 1990.
74. Ceman, S. and Sant, A., The function of invariant chain in class II-restricted antigen presentation, Sem. in Immunol., 7, 373-387, 1995.
75. Stern, L. J. and Wiley, D. C., The human class II MHC protein HLA-DR1 assembles as empty a/β heterodimers in the absence of antigenic peptides, Cell, 68, 465-477, 1992.
76. Schaiff, W. T., Hruska, K. Jr., McCourt, D. W., Green, M., and Schwartz, B. D., HLA-DR associates with specific stress proteins and is retained in the endoplasmic reticulum in invariant chain negative cells, J. Exp. Med., 176, 657-666, 1992.
77. Miller, J. and Germain, R. N., Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain, J. Exp. Med., 164, 1478-1489, 1986.
78. Schaiff, W. T., Hruska, K. Jr., Bono, C., Shuman, S., and Schwartz, B. D., Invariant chain influences post-translational processing of HLA-DR molecules, J. Immunol., 147, 603-608, 1991.
79. Anderson, M. S. and Miller, J., Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules, Proc. Natl. Acad. Sci. U.S.A., 89, 2282-2286, 1992.
80. Neefjes, J. J., Stollorz, V., Peters, P. J., Geuze, H. J., and Ploegh, H. L., The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route, Cell, 61, 171-183, 1990.
81. Davidson, H. W., Reid, P. A., Lanzavecchia, A., and Watts, C., Processed antigen binds to newly synthesized MHC class II molecules in antigen-specific B lymphocytes, Cell, 67, 105-116, 1991.
82. Bénaroch, P., Yilla, M., Raposo, G., Ito, K., Miwa, K., Geuze, H. J., and Ploegh, H. L., How MHC class II molecules reach the endocytic pathway, EMBO J., 14, 37-49, 1995.
83. Roche,P. A., Teletski, C. L., Karp, D. R., Pinet, V., Bakke, O., and Long, E, O., Stable surface expression of invariant chain prevents peptide presentation by HLA-DR, EMBO J., 11, 2841-2847, 1992.
84. Simonsen, A., Momburg, F., Drexler, J., Hämmerling, G. J., and Bakke, O., Intracellular distribution of the MHC class II molecules and the associated invariant chain (Ii) in different cell lines, Int. Immunol., 5, 903-917, 1993.
85. Bremnes, B., Madsen, T., Gedde-Dahl, M., and Bakke, O., An LI and ML motif in the cytoplasmic tail of the MHC-associated invariant chain mediate rapid internalization, J. Cell Sci, 107, 2021-2032, 1994.
86. Odorizzi, C. G., Trowbridge, I. S., Xue, L., Hopkins, C. R., Davis, C. D., and Collawn, J. F., Sorting signals in the MHC class II invariant chain cytoplasmic tail and transmembrane region determine trafficking to an endocytic processing compartment, J. Cell Biol., 126, 317-330, 1994.
87. Pond, L., Kuhn, L. A., Teyton, L., Schultze, M. P., Tainer, J. A., Jackson, M. R., and Peterson, P. A., A role for acidic residues in di-leucine motif-based targeting to the endocytic pathway, J. Biol. Chem., 270, 19989-19997, 1995.
88. Swier, K. and Miller, J., Invariant chain-independent antigen presentation depends primarily upon the pool of newly synthesized MHC class II molecules, J. Immunol., 155, 1851-1861, 1995.
89. Wraight, C. J., van Endert, P., Moller, P., Lipp, J., Ling, N. R., MacLennan, I. E., Koch, N., and Moldenhauer, G., Human major histocompatibility complex class II invariant chain is expressed on the cell surface, J. Biol. Chem., 265, 5787-5792, 1990.
90. Koch, N., Moldenhauer, G., Hofmann, W. J., and Moller, P., Rapid intracellular pathway gives rise to cell surface expression of the MHC class II-associated invariant chain (CD74), J. Immunol., 147, 2643-2651, 1991.
91. Wilson, K. M., Labeta, M. O., Pawelec, G., and Fernandez, N., Cell-surface expression of human histocompatibility leukocyte antigen (HLA) class II-associated invariant chain (CD74) does not always correlate with cell-surface expression of HLA class II molecules, Immunol., 79, 331-335, 1993.
92. Henne, C., Schwenk, F., Koch, N., and Moller, P., Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens, Immunology; 84, 177-182, 1995.
93. Roche, P. A., Teletski, C. L., Stang, E., Bakke, O., and Long, E. O., Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization, Proc. Natl. Acad. Sci. U.S.A., 90, 8581-8585, 1993.
94. Miller, J., Endosomal localization of MHC class II-invariant chain complexes, Immunol. Res., 13, 244-252, 1994.
95. Salamero, J., Humbert, M., Cosson, P., and Davoust, J., Mouse B lymphocyte specific endocytosis and recycling of MHC class II molecules, EMBO J., 9, 3489-3494, 1990.
96. Chervonsky, A. V., Gordon, L., and Sant. A., A segment of MHC class II β chain plays a critical role in targeting class II molecules to the endocytic pathway, Int. Immunol., 6, 973-982, 1994.
97. Cresswell, P., Intracellular class II HLA antigens are accessible to transferrin-neuraminidase conjugates internalized by receptor-mediated endocytosis, Proc. Natl. Acad. Sci U.S.A., 82, 8188-8192, 1985.
98. Guagliardi, L. E., Koppelman, B., Blum, J. S., Marks, M. S., Cresswell, P., and Brodsky, F. M., Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment, Nature, 343, 133-139, 1990.
99. Amigorena, S., Webster, P., Drake, J., Newcomb, J., Cresswell, P., and Mellman, I., Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles, J. Exp. Med., 181, 1729-1741, 1995.
100. Castellino, F. and Germain, R. N., Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptideloaded class II in multiple compartments, Immunity, 2, 73-88, 1995.
101. Gorvel, J. P., Escola, J. M., Stang, E., and Bakke, O., Invariant chain induces a delayed transport from early to late endosomes, J. Biol. Chem., 270, 2741-2746, 1995.
102. Peters, P. J., Neefjes, J. J., Oorschot, V., Ploegh, H. L., and Geuze, H. J., Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments, Nature, 349, 669-676, 1991.
103. Xu, X. X., Song, W. X., Cho, H., Qiu, Y., and Pierce, S. K., Intracellular transport of invariant chain MHC class II complexes to the peptide-loading compartment, J. Immunol., 155, 2984-2992, 1995.
104. Tulp, A., Verwoerd, D., Dobberstein, B., Ploegh, H. L., and Pieters, J., Isolation and characterization of the intracellular MHC class II compartment, Nature, 369, 120-126, 1994.
105. West, M. A., Lucocq, J. M., and Watts, C., Antigen processing and class II MHC peptide loading compartments in human B-lymphoblastoid cells, Nature, 369, 147-150, 1994.
106. Amigorena, S., Drake, J. R., Webster, P., and Mellman, I., Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes, 369, 113-120, 1994.
107. Qiu, Y., Xu, X., Wandinger-Ness, A., Dalke, D. P., and Pierce, S. K., Separation of subcellular compartments containing distinct functional forms of MHC class II, J. Cell Biol., 125, 595-605, 1994.
108. Kleijmeer, M. J., Ossevoort, M. A., van Veen, C. J. H., van Hellemond, J. J., Neefjes, J. J., Kast, W. M., Melief, C. J. M., and Geuze, J. J., MHC class II compartments and the kinetics of antigen presentation in activated mouse spleen dendritic cells, J. Immunol., 154, 5715-5724, 1995.
109. Karlsson, L., Péléraux, A., Lindstedt, R., Liljedahl, M., and Peterson, P. A., Reconstitution of an operational MHC class II compartment in nonantigen-presenting cells, Science, 266, 1569-1573, 1994.
110. Riberdy, J. M., Avva, R. R., Geuze, H. J., and Cresswell, P., Transport and intracellular distribution of MHC class II molecules and associated invariant chain in normal and antigen-processing mutant cell lines, J. Cell Biol., 125, 1225-1237, 1994.
111. Harding, C. V. and Geuze, H. J., Immunogenic peptides bind to class II MHC molecules in an early lysosomal compartment, J. Immunol., 151, 3988-3998, 1993.
112. Neefjes, J. J. and Ploegh, H. L., Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistant αβ heterodimers, EMBO J., 11, 411-416, 1992.
113. Loss, G. E. and Sant, A. J., Invariant chain retains MHC class II molecules in the endocytic pathway, J. Immunol., 150, 3187-3197, 1993.
114. Maric, M. A., Taylor, M. D., and Blum, J. S., Endosomal aspartic proteinases are required for invariant-chain processing, Proc. Natl. Acad. Sci. U.S.A., 91, 2171-2175, 1994.
115. Morton, P. A., Zacheis, M. L., Giacoletto, K. S., Manning, J. A., and Schwartz, B. D., Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells, J. Immunol., 154, 137-150, 1995.
116. Mizuochi, T., Yee, S. T., Kasai, M., Kakiuchi, T., Muno, D., and Kominami, E., Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class IIMHC invariant chain, Immunol. Lett., 43, 189-193, 1994.
117. Pieters, J., Horstmann, H., Bakke, O., Griffiths, G., and Lipp, J., Intracellular transport and localization of Major Histocompatibility Complex class II molecules and associated invariant chain, J. Cell Biol., 115, 1213-1223, 1991.
118. Blum, J. S. and Cresswell, P., Role for intracellular proteases in the processing and transport of class II HLA antigens, Proc. Natl. Acad. Sci. U.S.A., 85, 3975-3979, 1988.
119. Nguyen, Q. V., Knapp, W., and Humphreys, R. E., Inhibition by leupeptine and antipaine of intracellular proteolysis of Ii, Hum. Immunol., 24, 153-163, 1989.
120. Zachgo, S., Dobberstein, B., and Griffiths, G., A block in degradation of MHC class II-associated invariant chain correlates with a reduction in transport from endosome carrier vesicles to the prelysosome compartment, J. Cell Sci., 103, 811-822, 1992.
121. Reyes, V. E., Lu, S., and Humphreys, R. E., Cathepsin B cleavage of Ii from class II MHC α- and β-chains, J. Immunol., 146, 3877-3880, 1991.
122. Mehringer, J. H., Harris, M. R., Kindle, C. S., McCourt, D. W., and Cullen, S. E., Characterization of fragments of the murine la-associated invariant chain, J. Immunol., 146, 920-927, 1991.
123. Thomas, L. J., Nguyem, Q. V., Elliot, W. L., and Humphreys, R. E., Proteolytic cleavage of Ii to p25, J. Immunol., 140, 2670-2674, 1988.
124. Morkowski, S., Goldrath, A. W., Eastman, S., Ramachandra, L., Freed, D. C., Whiteley, P., and Rudensky, A. Y., T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates, J. Exp. Med., 182, 1403-1413, 1995.
125. Riberdy, J. M., Newcomb, J. R., Surman, M. J., Barbosa, J. A., and Cresswell, P., HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides, Nature, 360, 414-477, 1992.
126. Sette, A., Ceman, S., Kubo, R. T., Sakaguchi, K., Appella, E., Hunt, D. F., Davis, T. A., Michel, H., Shabanowitz. J., Rudersdorf, R. et al., Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant, Science, 258, 1801-1814, 1992.
127. Chicz, R. M., Urban, R. G., Lane, W. S., Gorga, J. C., Stern, L. J., Vignali, D. A. A., and Strominger, J. L., Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size, Nature, 358, 764-768, 1992.
128. Malcherek, G., Gnau, V., Jung, G., Rammensee, H. G., and Melms, A., Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules, J. Exp. Med., 181, 527-536, 1995.
129. Liang, M. N., Beeson, C., Mason, K., and McConnell, H. M., Kinetics of the reactions between the invariant chain (85-99) peptide and proteins of the munne class II MHC. Int. Immunol., 7, 1397-1404, 1995.
130. d, Science, 256, 1817-1880, 1992.
131. Avva, R. R. and Cresswell, P., In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides, Immunity, 1, 763-774, 1994.
132. Bikoff, E. K., Germain, R. N., and Robertson, E. J., Allelic differences affecting invariant chain dependency of MHC class II subunit assembly, Immunity, 2, 301-310, 1995.
133. Sette, A., Southwood, S., Miller, J., and Appella, E., Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II, J. Exp. Med., 181, 677-683, 1995.
134. Adams, S. and Humphreys, R. E., Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules, Eur. J. Immunol., 25, 1693-1702, 1995.
135. Geluk, A., Van Meijgaarden, K. E., Drijfhout, J. W., and Ottenhoff, T., Clip binds to HLA class II using methionine-based, allele-dependent motifs as well as allele-independent supermotifs, Mol. Immunol., 32, 975-981, 1995.
136. Kropshofer, H., Vogt, A. B., and Hämmerling, G. J., Structural features of the invariant chain fragment CLIP controlling rapid release from HLA-DR molecules and inhibition of peptide binding, Proc. Natl. Acad. Sci. U.S.A., 92, 8313-8317, 1995.
137. Gautam, A. M., Pearson, C., Quinn, V., McDevitt, H. O., and Milburn, P. J., Binding of an invariant-chain peptide, CLIP, to I-A major histocompatibility complex class II molecules, Proc. Natl. Acad. Sci. U.S.A., 92, 335-339, 1995.
138. Ghosh, P., Amaya, M., Mellins, E., and Wiley, D. C., The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3, Nature, 378, 457-462, 1995.
139. Jensen, P., Regulation of antigen presentation by acidic pH, J. Exp. Med., 171, 1779-1784, 1990.
140. Wettstein, D. A., Boniface, J. J., Reay, P. A., Schild, H., and Davis, M., Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH, J. Exp. Med., 174, 219-228, 1991.
141. Reay, P. A., Wettstein, D. A., and Davis, M. M., pH dependence and exchange of high and low responder peptides binding to a class II MHC molecule, EMBO J., 11, 2829-2839, 1992.
142. Mouritsen, S., Stryhn Hansen, A., Laub Petersen, T., and Buus, S., pH dependence for an acidic intracellular compartment being the organelle of interac-tion, J. Immunol., 148, 1438-1444, 1992.
143. Sanderson, F., Kleijmeer, M. J., Kelly, A., Verwoerd, D., Tulp, A., Neefjes, J. J., Geuze, H. J., and Trowsdale, J., Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments, Science, 266, 1566-1569, 1994.
144. Nijman, H. W., Jleijmeer, M. J., Ossevoort, M. A., Oorschot, V. M. J., Vierboom, M. P. M., van de Keur, M., Kenemans, P., Kast, W. M., Geuze, H. J., and Melief, C. J. M., Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells, J. Exp. Med., 182, 163-174, 1995.
145. Sloan, V. S., Cameron, P., Porter, G., Gammon, M., Amaya, M., Mellins, E., and Zaller, D. M., Mediation by HLA-DM of dissociation of peptides from HLA-DR, Nature, 375, 802-806, 1995.
146. Denzin, L. K. and Cresswell, P., HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading, Cell, 82, 155-165, 1995.
147. Sherman, M. A., Weber, D. A., and Jensen, P. E., DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide, Immunity, 3, 197-205, 1995.
148. Sanderson, F., Thomas, C., Neefjes, J., and Trownsdale, J., Association between HLA-DM and HLA-DR in vivo, Immunity, 4, 87-96, 1996.
149. k class II molecules in human APC containing deleted or mutated HLA DM genes, J. Immunol., 153, 5382-5392, 1994.
150. Germain, R. N. and Hendrix, L. R., MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding, Nature, 353, 134-139, 1991.
151. Peterson, M. and Miller, J., Invariant chain influences the immunological recognition of MHC class II molecules, Nature, 345, 172-174, 1990.
152. Rath, S., Lin, R. H., Rudensky, A., and Janeway, C. Jr., T and B cell receptors discriminate major histocompatibility complex class II conformations influenced by the invariant chain, Eur. J. Immunol., 22, 2121-2127, 1992.
153. Hitzel, C., Van Endert, P., and Koch, N., Acquisition of peptides by MHC class II polypeptides in the absence of the invariant chain, J. Immunol., 154, 1048-1056, 1995.
154. Babbitt, B. P., Allen, P. M., Matsueda, G. R., Haber, E., and Unanue, E. R., Binding of immunogenic peptides to Ia histocompatibility molecules, Nature, 317, 359-361, 1985.
155. Buus, S. and Wederlin, O., A group-specific inhibitor of lysosomal cysteine proteinases selectively inhibits both proteolytic degradation and presentation of the antigen dinitrophenyl-poly-L-Lysine by guinea pig accessory cells to T cells, J. Immunol., 136, 452-460, 1986.
156. Roche, P. A. and Cresswell, P., Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature, 345, 615-618, 1990.
157. Roche, P. A. and Cresswell, P., Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules, Proc. Natl. Acad. Sci. U.S.A., 88, 3150-3154, 1991.
158. Bijlmakers, M. J., Benaroch, P., and Ploegh, H. L., Assembly of HLA DR1 molecules translated in vitro: binding of peptide in the endoplasmic reticulum precludes association with invariant chain, EMBO J., 13, 2699-2707, 1994.
159. Busch, R., Vturina, I. Y., Drexler, J., Momburg, F., and Hämmerling, G. J., Poor loading of major histocompatibility complex class II molecules with endogeneously synthesized short peptides in the absence of invariant chain, Eur. J. Immunol., 25, 48-53, 1995.
160. Ericson, M. L., Sundstrom, M., Sansom, D. M., and Charron, D. J., Mutually exclusive binding of peptide and invariant chain to major histocompatibility complex class II antigens, J. Biol. Chem., 269, 26531-26538, 1994.
161. Demotz, S., DR alpha-beta-dimers released from complexes with invariant chain fail to stimulate alloreactive T cell clones, Eur. J. Immunol., 23, 2100-2108, 1993.
162. Rudensky, A. Y., Preston-Hurlburt, P., Hong, S. C., Barlow, A., and Janeway, C. A., Sequence analysis of peptides bound to MHC class II molecules, Nature, 353, 622-627, 1991.
163. Rudensky, A. and Janeway, C. Jr., Studies on naturally processed peptides associated with MHC class II molecules, Chem. Immunol., 57, 134-151, 1993.
164. Calin-Laurens, V., Forquet, F., Lombard-Platet, S., Bertolino, P., Chretien, I., Trescol-Biemont, M. C., Gerlier, D., and Rabourdin-Combe, C., High efficiency of endogenous antigen presentation by MHC class II molecules, Int. Immunol., 4, 1113-1121, 1992.
165. Weiss, S. and Bogen, B., MHC Class II-restricted presentation of intracellular antigen, Cell, 64, 767-776, 1991.
166. Jacobson, S., Sekaly, R., Jacobson, C. L., McFarland, H. F., and Long, E. O., HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells, J. Virol., 63, 1756-1762, 1989.
167. Nuchtern, J. G., Biddison, W. E., and Klausner, R. D., Class-II MHC molecules can use the endogenous pathway of antigen presentation, Nature, 343, 74-76, 1990.
168. Jaraquemada, D., Marti, M., and Long, E., An endogenous processing pathway in vaccinia virusinfected cells for presentation of cytoplasmic antigens to class II-restricted T cells, J. Exp. Med., 172, 947-952, 1990.
169. Bikoff, E., Class II-restricted IgG2ab-specific T cells recognize a signal-minus form of the V-Ch3b antigen, Eur. J. Immunol., 21, 1411-1417, 1991.
170. Brooks, A., Hartley, S., Kjer-NIelsen, L., Perera, J., Goodnow, C. C., Basten, A., and McCluskey, J., Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme, Proc. Natl. Acad. Sci. U.S.A., 88, 3290-3294, 1991.
171. Malnati, M. S., Ceman, S., Weston, M., Demars, R., and Long, E. O., Presentation of cytosolic antigen by HLA-DR requires a function encoded in the class-II region of the MHC, J. Immunol., 151, 6751-6756, 1993.
172. Lombard-Platet, S., Bertolino, P., Gimenez, C., Humbert, M., Gerlier, D., and Rabourdin-Combe, C., Invariant chain expression similarly controls presentation of endogenously synthesized and exogenous antigens by MHC class II molecules, Cell Immunol., 148, 60-70, 1993.
173. Long, E. O., LaVaute, T., Pinet, V., and Jaraquemada, D., Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide, J. Immunol., 153, 1487-1494, 1994.
174. Bodmer, H., Viville, S., Benoist, C., and Mathis, D., Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain, Science, 263, 1284-1286, 1994.
175. Michalek, M. T., Benacerraf, B., and Rock, K. L., The class II MHC-restricted presentation of endogenously synthesized ovalbumin displays clonal variation, requires endosomal/lysosomal processing, and is up-regulated by heat shock, J. Immunol., 148, 1016-1024, 1992.
176. Moreno, J., Vignali, D. A. A., Nadimi, F., Fuchs, S., Adorini, L., and Hämmerling, G. J., Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen, J. Immunol., 147, 3306-3313, 1991.
177. Eager, K. B., Hackett, C. J., Gerhard, W. U., Bennink, J., Eisenlohr, L. C., Yewdell, J., and Ricciardi, R. P., Mutine cell lines stably expressing the influenza virus hemagglutinin gene introduced by a recombinant retrovirus vector are constitutive targets for MHC class I- and class II-restricted T lymphocytes, J. Immunol., 143, 2328-2335, 1989.
178. + cytotoxic T cell recognition of endogenously processed antigen, J. Immunol., 144, 2789-2794, 1990.
179. Lee, S. P., Wallace, L. E., Mackett, M., Arrand, J. R., Searle, P. F., Rowe, M., and Rickinson, A. B., MHC class II-restricted presentation of endogenously synthesized antigen: Epstein-Barr virus transformed B cell lines can present the viral glycoprotein gp340 by two distinct pathways, Int. Immunol., 5, 451-460, 1993.
180. Nadimi, F., Moreno, J., Momburg, F., Heuser, A., Fuchs, S., Adorini, L., and Hämmerling, G. J., Antigen presentation of hen egg-white lysozyme but not of ribonuclease A is augmented by the major histocompatibility complex class II-associated invariant chain, Eur. J. Immunol., 21, 1255-1263, 1991.
181. Humbert, M., Bertolino, P., Forquet, F., RabourdinCombe, C., Gerlier, D., Davoust, J., and Salamero, J., Major histocompatibility complex class II-restricted presentation of secreted and endoplasmic reticulum resident antigens requires the invariant chains and is sensitive to lysosomotropic agents, Eur. J. Immunol., 23, 3167-3172, 1993.
182. Momburg, F., Fuchs, S., Drexler, J., Busch, R., Post, M., Hämmerling, G. J., and Adorini, L., Epitope-specific enhancement of antigen presentation by invariant chain, J. Exp. Med., 178, 1453-1458, 1993.
183. Shachar, I., Elliott, E. A., Chasnoff, B., Grewal, I. S., and Flavell, R. A., Reconstitution of invariant chain function in transgenic mice in vivo by individual p31 and p41 isoforms, Immunity, 3, 373-383, 1995.
184. + T cell function in mice lacking the p41 isoform of invariant chain, Immunity, 3, 385-396, 1995.
185. Fineschi, B., Arneson, L., Naujokas, M. F., and Miller, J., Proteolysis of major histocompatibility complex class II-associated invariant chain is regulated by the alternatively spliced gene product, p41, Proc. Natl. Acad. Sci. U.S.A., 92, 10257-10261, 1995.
186. Ogrinc, T., Dolenc, I., Ritonja, A., and Turk, V., Purification of the complex of cathepsin L and the MHC-class II-associated invariant chain fragment from human kidney, FEBS Lett., 336, 555-559, 1993.
187. + T cell development, Immunity, 3, 359-372, 1995.
188. Tourne, S., Nakano, N., Viville, S., Benoist, C., and Mathis, D., The influence of invariant chain on the positive selection of single T cell receptor specificities, Eur. J. Immunol., 25, 1851-1856, 1995.
189. Kampgen, E., Koch, N., Koch, F., Stoger, P., Heufler, C., Schuler, G., and Romani, N., Class II major histocompatibility complex molecules of murine dendritic cells: synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture, Proc. Natl. Acad. Sci. U.S.A., 88, 3014-3018, 1991.